Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride 5-mg oral disintegrating tablets and standard tablets are bioequivalent in healthy adult male Han Chinese volunteers.

Bubble-based systems show promise for precise, targeted drug delivery and diagnosis, especially in cancer treatment.

New small molecule drugs show promise in treating complex skin diseases but need more safety research.

Adding baricitinib will increase costs but offers more treatment options for alopecia areata.

Microemulsions can effectively deliver drugs through the skin but require careful ingredient selection to avoid irritation.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

DLP bioprinting shows promise for medical uses, but needs more material options and strength improvements.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Engineered cytokines show promise for improving tissue healing and safety in regenerative medicine.

A new topical treatment using SAMiRNA technology shows promise in increasing hair growth for androgenetic alopecia.

Serum WS Biotin significantly reduces hair shedding and improves hair thickness.

DiluCap improves how quickly minoxidil and finasteride dissolve and controls the release of melatonin and naltrexone.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Social media can help compare the effectiveness and safety of new arthritis medications.

The study created a new type of microsphere that effectively regrows hair.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Oncology specialists are disappointed by the discontinuation of the effective lymphoma treatment Bexxar.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Method measures latanoprost and minoxidil in skin accurately and precisely.

New nanocarriers improve skin drug delivery with low toxicity at certain concentrations.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Nanoemulgel is a better way to deliver drugs through the skin for various conditions.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

Hydrogel composites have great potential in regenerative medicine, tissue engineering, and drug delivery.